Global Market Study on Mammalian Cell Banking: Increasing Focus on Oncological Research Surging Market Growth


Mammalian Cell Banking  Market
  • Published On : Jul-2020 |
  • Pages : 251 Pages |
  • Format : Mammalian Cell Banking  Market Mammalian Cell Banking  Market Mammalian Cell Banking  Market Mammalian Cell Banking  Market

Potentially, mammalian cell culture has helped oncology research the most, as cancer cells are more responsive to culture in vitro. Cell lines provide an indefinite source of biological material for experimental purposes. Funding for cancer research from government authorities in Asia Pacific are increasing the scope for mammalian cell bank service providers. For instance, in 2019, Cancer Research U.K. and the Indian government’s Department of Biotechnology launched a US$ 12.7 Mn, 5-year initiative.

Rising burden of cancer cases is increasing the demand for preclinical studies. This is the key factor increasing the mammalian cell banking market size.

The National Cancer Institute (NCI) along with other institutes invest in major research initiatives to facilitate and support research on specific issues of importance to the cancer research enterprise. These initiatives include Cancer Moonshot, The National Clinical Trials Network (NCTN), NCI Genomic Data Commons (GDC), the RAS Initiative, NCI Community Oncology Research Program (NCORP), etc. 

Financial support for cancer research by government and non-governmental organizations is growing, which will boost the growth of the mammalian cell banking market over the coming years.

Mammalian Cell Banking Market Trends

Mammalian cells are regularly used in the biopharmaceutical industry for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry.

Improved post cryopreservation technology is used by cell banks to improve cell recovery. Additionally, cryopreserved cell lines are provided in multiple vials to prevent potential contamination and genetic variation by eliminating the multiple handling and revive processes of cell lines during the research process. This will increase product adaption amongst researchers. It will also lead to successful cryopreservation of cell lines that play a key role in establishing viable biopharmaceutical production processes. Moreover, cryopreservation is more significant than traditional protocols for cell preservation. This is a key factor anticipated to aid the growth of the mammalian cell banking market.

Regional Outlook of Mammalian Cell Banking Market

North America and Europe currently hold more than 49% of the global mammalian cell banking market share. High prevalence of cancer and increasing cancer research are surging the demand for mammalian cell banking in North America.

However, the market East Asia and South Asia will experience significant growth over the forecast period, owing to factors such as increased burden of cancer, large population base, and tremendous use of cell lines for research projects. Increased R&D investments and government initiatives are expected to boost the demand for mammalian cell banking in these regions.

Impact of COVID-19 Pandemic on Mammalian Cell Banking Market

The COVID-19 pandemic will have a positive impact on the progress of the mammalian cell banking market. Potential research is going on for COVID-19 vaccines. During clinical trials of COVID-19 vaccines, demand for cell lines has increased. This will boost the growth of the mammalian cell banking market. This is benefiting the stock prices of biopharmaceutical industries, which will complement the growth of the mammalian cell banking market.

Analysts’ Viewpoint

An extensive analysis of the mammalian cell banking market has brought our analysts to a conclusion that, the market is growing at a significant pace. Currently, CHO cells is the target segment for major players, and hence, this segment dominates the global mammalian cell banking market in term of growth. Europe and North America collectively hold more than 50% revenue share, due to high adoption of mammalian cell banking in these regions. Emerging countries such as Brazil, China, and India are expected to offer lucrative opportunities for players in the mammalian cell banking market, owing to increasing awareness and initiatives by local governments for research & development on cancer.

Mammalian Cell Banking Market - Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global mammalian cell banking market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global mammalian cell banking market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the mammalian cell banking market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for successful growth of the mammalian cell banking market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR). This research study can support readers to know the demand for mammalian cell banking and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the mammalian cell banking market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the mammalian cell banking market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the mammalian cell banking market, industry experts, investors, researchers, and reporters, as well as mammalian cell banking business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the mammalian cell banking market are also included in the current study. Depending on potential developments in the mammalian cell banking market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this mammalian cell banking market report, minor companies and new entrants in the mammalian cell banking industry can be aided in making suitable company choices to achieve traction in the market.

Key Segments of Mammalian Cell Banking Market

PMR’s study on the mammalian cell banking market offers information divided into five important segments— cell, technology, cell bank , end user, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.

Cell

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology

  • Transient Expression Platforms
  • Inducible Expression Platforms
  • Stable Expression Platforms

Cell Bank

  • Master Cell Banks (MCBs)
  • Working Cell Banks (WCBs)
  • End of Production Cell Banks (EoPCBs)
  • Research & Development Cell Banks (R&D CBs)

End User

  • Academic & Research Laboratories
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in PMR’s Mammalian Cell Banking Market Report

  • Which regions will continue to remain the most profitable regional markets for mammalian cell banking market players?
  • Which factors will induce a change in the demand for mammalian cell banking during the assessment period?
  • How will changing trends impact the mammalian cell banking market?
  • How can market players capture the low-hanging opportunities in the mammalian cell banking in developed regions?
  • What are the winning strategies of stakeholders in the mammalian cell banking market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the mammalian cell banking market?
  • What are the developmental trends in the mammalian cell banking sectors that will impact the market?
  • How can businesses in the mammalian cell banking market avail the growth opportunities in developed and emerging sectors?

Mammalian Cell Banking Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the mammalian cell banking market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of mammalian cell banking market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the mammalian cell banking market, and makes PMR’s projections on the growth prospects of the mammalian cell banking market more accurate and reliable.

Companies covered in Mammalian Cell Banking Market Report

  • Sartorius Stedim BioOutsource Limited.
  • Charles River Laboratories.
  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Lonza Group Ltd
  • VIRUSURE
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Selexis SA

Mammalian Cell Banking Market

Back To Top